版本:
中国

BRIEF-Recro Pharma presents Phase III bunionectomy clinical data for IV meloxicam

May 18 Recro Pharma Inc

* Recro Pharma presents Phase III bunionectomy clinical data for IV meloxicam at the American Pain Society 36th annual scientific meeting

* Recro Pharma - data from late-stage trial demonstrate iv meloxicam 30mg provides rapid and sustained pain relief following bunionectomy surgery Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐